US$ 20.95
3rd generation glp 1 agonist third Understanding the Next-Gen Weight Loss Drug: Retatrutide (GLP-1, GIP, and Upcoming wave of hormone-based therapies
Description
What are the cardiovascular benefits of GLP-1 agonists

Cancers (Basel)

Understanding what follows helps contextualize the first 12 weeks within the larger weight loss journey

A.BloomS
GLP-1 inhibits adenosine triphosphate (ATP)-regulated potassium (K + )channels, increases activity of L-type voltage gated calcium channels, and triggers opening of non-specific cation channels through PKA and exchange protein directly activated by cAMP (EPAC), two cAMP-dependent processes [48], [49]
